Elevated incidence of hematologic malignancies in patients with Sjogren's syndrome compared with patients with rheumatoid arthritis (Finland)

Cancer Causes and Control

Volumn 8, Issue 2, 1997, Pages 201-204

  Kauppi, Markku ^a   Pukkala, Eero ^b   Isomäki, Heikki ^c  

^a RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Finland; lymphoma; rheumatoid arthritis; Sjogren's syndrome

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FINLAND; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME;

ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FINLAND; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; MALE; POISSON DISTRIBUTION; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; SJOGREN'S SYNDROME; SURVIVAL RATE;

EID: 0030942071     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018472213872     Document Type: Article

References (22)

1. Santana V, Rose NR. Neoplastic lymphoproliferation in autoimmune disease: An updated review. Clin Immunol Immunopathol 1992; 63: 205-13.
2. Holm LE, Blomgren H, Löwhagen T. Cancer risk in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312: 601-4.
3. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Int Med 1978; 89: 888-92.
4. Isomäki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chron Dis 1978; 31: 691-6.
5. Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. JNCI 1993; 85: 307-11.
6. Silman AJ, Petrie J, Hazleman B, Evans SJW. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20-year follow-up study. Ann Rheum Dis 1988; 47: 988-92.
7. Tennis P, Andrews E, Bombardier C, et al. Record linkage to conduct an epidemiological study on the association of rheumatoid arthritis and lymphoma in the province of Saskatchewan, Canada. J Clin Epidemiol 1993; 46: 685-95.
8. Abbatt JD, Lea AJ. Leukaemogens. Lancet 1958; 2: 880-3.
9. Gridley G, Klippel JH, Hoover RN, Fraumeni JF Jr. Incidence of cancer among men with the Felty syndrome. Ann Intern Med 1994; 120: 35-9.
10. Plachecka M, Polowiec Z, Abgarowicz-Milkowska T, et al. Lymphoreticular proliferative syndromes in rheumatoid diseases. 'R' 1977; 6: 575-82.
11. Eriksson M. Rheumatoid arthritis as a risk factor for multiple myeloma: a case-control study. Eur J Cancer 1993; 29A: 259-63.
12. Ichikawa Y, Takaya M, Shimizu H, et al. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjogren's syndrome, secondary Sjogren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease. Tokai J Exp Clin Med 1993; 18: 133-8.
13. Prior P. Cancer and rheumatoid arthritis: epidemiological considerations. Am J Med 1985; 78(1A): 15-21.
14. Myllykangas-Luosujärvi R, Aho K, Isomäki H. Mortality from cancer in patients with rheumatoid arthritis. Scand J Rheumatol 1995; 24: 76-8.
15. Kamel OW, van de Rijn M, LeBrun DP, Weiss LM, Warnke RA, Dorfman RF. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 1994; 25: 638-43.
16. Bachman TR, Sawitzke AD, Perkins SL, Ward JH, Cannon GW. Methotrexate-associated lymphoma in patients with rheumatoid arthritis. Arthritis Rheum 1996; 39: 325-9.
17. Kalden JR, Winkler T, Krapf F. Are retroviruses involved in the aetiology of rheumatic diseases? Brit J Rheumatol 1991; 30: 63-9.
18. Kinlen L, Skeil A, Peto R, Doll R. Collaborative UK-Australasian study of cancer in patients treated with immunosuppressive drugs. Brit Med J 1979; 2: 1461-6.
19. Baltus J, Boersma J, Hartman A, Vandenbroucke J. Occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up. Ann Rheum Dis 1983; 42: 368-73.
20. Kauppi M, Savolainen HA, Anttila V-J, Isomäki HA. Increased risk of leukaemia in patients with juvenile chronic arthritis treated with chlorambucil. Acta Paediatr 1996; 85: 248-50.
21. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342: 1514-6.
22. Talal N, Bunim JJ. Development of malignant lymphoma in the course of Sjögren's syndrome. Am J Med 1964; 36: 529-40.